Study finds why some don't respond to rubella vaccine

Using advanced genetic sequencing technology and analysis, Mayo Clinic vaccine researchers have identified 27 genes that respond in very different ways to the standard rubella vaccine, making the vaccine less effective for a portion of the population. The findings appear today in the online journal PLOS ONE.

"This study highlighted the genes potentially responsible for poor response to the rubella vaccine," says Mayo Clinic vaccinologist Gregory Poland, M.D. "We found differences in genes responsible for antigen interactions, inflammation and differences in the gene pathways involved between low and high vaccine responders. It's another instance of using individualized medicine approaches to find potential solutions for patients not benefiting from standard treatments."

Researchers in the Mayo Clinic Group began with a random sample of 738 healthy children and young adults who had had two doses of the MMR (measles, mumps, and rubella) vaccine and then selected 25 individuals who represented either high or low responders. Samples from those participants were subject to sequencing of , resulting in transcriptional data that was analyzed for differences in gene expression.

This was the first Next Generation (high-speed, high-throughput) and analysis conducted after rubella vaccination that provided quantitative data. Researchers say the findings will help in efforts to better understand reactions to the existing rubella vaccine and be very useful in developing alternative vaccines so individuals in the low-response group can be adequately protected.

add to favorites email to friend print save as pdf

Related Stories

Third MMR vaccine dose can curtail mumps outbreak

Nov 05, 2012

(HealthDay)—Administering a third dose of the measles-mumps-rubella (MMR) vaccine reduced the village-wide attack rate by about 75 percent in a community experiencing a large mumps outbreak despite a high ...

Recommended for you

Some immune cells defend only one organ

4 hours ago

(Medical Xpress)—Scientists have uncovered a new way the immune system may fight cancers and viral infections. The finding could aid efforts to use immune cells to treat illness.

Taking the sting out of insect-sting allergies

Apr 11, 2014

(Medical Xpress)—Certain people with a history of systemic allergic reactions to insect stings are likely to benefit from immunotherapy to prevent life-threatening anaphylaxis and should, at the very least, ...

Sensitive balance in the immune system

Apr 11, 2014

Apoptosis is used by cells that are changed by disease or are simply not needed any longer to eliminate themselves before they become a hazard to the body—on a cellular level, death is part of life. Disruption ...

User comments